tezacaftor 50 MG
RxNorm concept 2174386, clinical drug component (scdc).
- RxCUI
- 2174386
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2174386 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet (SCD, constitutes)
- elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet (SCD, constitutes)
- elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules (SCD, constitutes)
- deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG Oral Tablet (SCD, constitutes)
- deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG Oral Tablet [Alyftrek] (SBD, constitutes)
- tezacaftor (IN, has ingredient)
- deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG [Alyftrek] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2174386 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2174386 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2174386. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.